You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 60 No. 5_PART_I, November 1949 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

USE OF REPELLENTS IN CLINICAL DERMATOLOGY

General Principles

LEON GOLDMAN, M.D.

Arch Derm Syphilol. 1949;60(5 PART I):777-780.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

AMONG the advances in preventive medicine in the last world war were the detailed studies in the chemical control of insects. As yet, the practicing physician, as compared with the military physician, does not appear to be fully aware of the possibilities for the control of insects, especially the disease-bearing types. This chemical control, in general, falls into two phases: insecticidal and repellent activity.

The development of insecticides is well known from the advances in the preparations of pyrethrins and DDT (2,2-bis [p-chlorophenyl]-1,1,1-trichloroethane) and its newer analogues, such as DDD (1,1-dichloro-2,2-bis-[p-chlorophenyl]-ethane) and methoxychlor (1,1,1trichloro-2,2-bis [p-methoxyphenyl]-ethane. Perhaps less is known about the developments of new insecticidal materials, which include such substances as gammexane® (hexachlorocyclohexane), velsicol 1068® (also called chlordan), hexaethyltetraphosphate, piperine compounds, parathion (0,0-diethyl-0-p-nitrophenyl thiophosphate), very toxic, phenyl cellosolve® (ethylene glycol monophenyl ether) and eura® (10 per cent crotonyl-N-ethyl-ortho-toluidide).1 Dermatologists should be interested also in the . . . [Full Text PDF of this Article]


Author Affiliations

CINCINNATI

From the Department of Dermatology and Syphilology of the University of Cincinnati College of Medicine.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1949 American Medical Association. All Rights Reserved.